Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin

OBJECTIVE: Use of gastric bypass surgery is common and increasing. Over 40% of patients in diabetes remission after gastric bypass surgery may redevelop diabetes within 5 years. Metformin, the first-line drug for diabetes, has low bioavailability and slow, incomplete gastrointestinal absorption. We...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Padwal, Raj S., Gabr, Raniah Q., Sharma, Arya M., Langkaas, Lee-Ann, Birch, Dan W., Karmali, Shahzeer, Brocks, Dion R.
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2011
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3114332/
https://ncbi.nlm.nih.gov/pubmed/21478461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-2140
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires